Henry M. Spotnitz, MD, Daniel Y. Wang, MD

Slides:

Advertisements

Similar presentations

Tubular heart valves: A new tissue prosthesis design—Preclinical evaluation of the 3F aortic bioprosthesis James L. Cox, MD, Niv Ad, MD, Keith Myers, BS,

Advertisements

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Of mice and men and surgical transcatheter aortic valve insertion

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Stephen R. Broderick, MD, MPHS

Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters Victor Dayan, MD, PhD, Philippe Pibarot,

Alan P. Kypson, MD, David W. Frazier, MD, Jon F. Moran, MD

Right internal thoracic artery or saphenous vein grafting

Intrinsic cardiac stem cells are essential for regeneration

Abracadabra I, II…HeartMate 3?

Form ever follows function

Vinod Havalad, MD, Matthew Bacchetta, MD, Daniel Y. Wang, MD, Santos E

How should we treat air leaks?

Resuscitation practices in cardiac surgery

Quadruple valve replacement in patients with carcinoid heart disease

Bicuspid aortic valve aortopathy: One size fits all?

Commentary: Pursuit of the green jacket: Mastery of the long and short games Daniel P. Raymond, MD The Journal of Thoracic and Cardiovascular Surgery

Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement Ole Lund, MD, PhD, Martin Bland,

The lord of the rings Antonio Miceli, MD, PhD

Erick M. Carreras, Walter J

The variability of the mitral valve anatomy and terminology

Juan N. Pulido, MD The Journal of Thoracic and Cardiovascular Surgery

Support Your Specialty

Michael Mack, MD, David Taggart, MD

Transcatheter aortic valve replacement in intermediate-risk patients

Innovation and science: The future of valve design

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

It's not “just a shunt” but sometimes it should be…

Michele Gallo, MD, Gino Gerosa, MD

Military surgeons just want to have fun

Right ventricular failure after cardiac surgery: Why can't right ventricular assist device support fix the problem? Francis D. Pagani, MD, PhD The Journal.

Stephen R. Broderick, MD, MPHS

Torsten Doenst, MD, PhD, Markus Richter, MD

The Journal of Thoracic and Cardiovascular Surgery

The Journal of Thoracic and Cardiovascular Surgery

Choice of second pericardial drainage tube for posterior placement

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Niv Ad, MD, Lawrence M. Wei, MD

Daniel T. Engelman, MD, FACS, Michael J. Germain, MD

The Journal of Thoracic and Cardiovascular Surgery

Replicating the success of mitral valve repair in the aortic valve

Commentary: Ongoing advancements in the understanding of tricuspid valve dynamics and functional geometry Daniel J.P. Burns, MD, MPhil The Journal of.

Commentary: Do the right thing! Ethical versus legal

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

How much is enough to warrant prophylactic tricuspid repair?

Biomaterials for heart valve replacement: Conjectures and refutations

Functional tricuspid pathology: To treat or not to treat

Warfarin or aspirin after mitral valve repair: Why work harder?

Hans-Joachim Schäfers, MD

The harder one looks, the more one finds

Concomitant replacement of the ascending aorta is free—for some

First nights, the adrenal axis, and steroids

The origins of open heart surgery at the University of Minnesota 1951 to 1956 Richard A. DeWall, MD The Journal of Thoracic and Cardiovascular Surgery

Constantine L. Athanasuleas, MD, FACC

Early extubation after cardiac surgery: The evolution continues

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Severe tricuspid or mitral regurgitation in inoperable patients with aortic stenosis. Can we leave them alone? Juan A. Crestanello, MD The Journal of.

The future of cardiac surgery training: A survival guide

Commentary: “Isn't cardiac surgery a team sport?”

Ventricular assistant in restrictive cardiomyopathy: Making the right connection Robert D.B. Jaquiss, MD The Journal of Thoracic and Cardiovascular Surgery

Permanent pacemaker insertion following transcatheter aortic valve replacement: Not infrequent, not benign, and becoming predictable Craig M. Jarrett,

After neoadjuvant chemoradiation therapy, predicted pulmonary function may be reduced by 10% Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular.

“The more things change…”: The challenges ahead

First in line for robotic surgery: Would you want to know?

Apples remain apples NO matter what

Preoperative PFTs: The answer is blowing in the wind

Which biologic valve should we select for the 45- to 65-year-old age group requiring aortic valve replacement? F. Dagenais, MD, P. Cartier, MD, P. Voisine,

Journal changes and initiatives

Lessons learned from Melody valve retrieved at transplantation

Presentation transcript:

Middle and posterior cardiac veins: An underused option for ventricular pacing Henry M. Spotnitz, MD, Daniel Y. Wang, MD The Journal of Thoracic and Cardiovascular Surgery Volume 143, Issue 5, Pages 1223-1225 (May 2012) DOI: 10.1016/j.jtcvs.2011.10.075 Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Posteroanterior (A) and lateral (B) radiographs of patient 1 with DDD pacemaker, including ventricular pacing with a bipolar lead in a posterior cardiac vein. This patient had previously undergone 3 cardiac operations, including tricuspid valve replacement with a mechanical prosthesis. The Journal of Thoracic and Cardiovascular Surgery 2012 143, 1223-1225DOI: (10.1016/j.jtcvs.2011.10.075) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Posteroanterior (A) and lateral (B) radiographs of patient 2 with biventricular pacemaker, including ventricular pacing with a bipolar lead in a posterior or middle cardiac vein. This patient had previously undergone 5 cardiac operations, including 3 tricuspid valve replacements with a bioprosthesis. The Journal of Thoracic and Cardiovascular Surgery 2012 143, 1223-1225DOI: (10.1016/j.jtcvs.2011.10.075) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions